Scientific Literature Search

Source record

A GCase chaperone improves motor function in a mouse model of synucleinopathy.

Richter F, Fleming SM, Watson M, Lemesre V, Pellegrino L, Ranes B, Zhu C, Mortazavi F, Mulligan CK, Sioshansi PC, Hean S, De La Rosa K, Khanna R, Flanagan J, Lockhart DJ, Wustman BA, Clark SW, Chesselet MF.

Neurotherapeutics · 2014-10-01

DOI: 10.1007/s13311-014-0294-xPMID: 25037721

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Modulation of alpha-synuclein toxicity in yeast using a novel microfluidic-based gradient generator.

Fernandes JT, Tenreiro S, Gameiro A, Chu V, Outeiro TF, Conde JP.

Lab Chip · 2014-10-01

DOI: 10.1039/c4lc00756ePMID: 25167219

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Genetic characterization of cognitive impairment in Parkinson's disease.

Dujardin K, Devos D.

Brain · 2014-10-01

DOI: 10.1093/brain/awu218PMID: 25217791

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Early oligomerization stages for the non-amyloid component of α-synuclein amyloid.

Eugene C, Laghaei R, Mousseau N.

J Chem Phys · 2014-10-01

DOI: 10.1063/1.4896381PMID: 25296841

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Mutant α-synuclein enhances firing frequencies in dopamine substantia nigra neurons by oxidative impairment of A-type potassium channels.

Subramaniam M, Althof D, Gispert S, Schwenk J, Auburger G, Kulik A, Fakler B, Roeper J.

J Neurosci · 2014-10-01

DOI: 10.1523/jneurosci.5069-13.2014PMID: 25297088

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Skin nerve α-synuclein deposits: a biomarker for idiopathic Parkinson disease.

Sharma SK.

Neurology · 2014-10-01

DOI: 10.1212/wnl.0000000000000973PMID: 25332447

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Acute increase of α-synuclein inhibits synaptic vesicle recycling evoked during intense stimulation.

Busch DJ, Oliphint PA, Walsh RB, Banks SM, Woods WS, George JM, Morgan JR.

Mol Biol Cell · 2014-10-01

DOI: 10.1091/mbc.e14-02-0708PMID: 25273557

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?

Saunders-Pullman R, Mirelman A, Wang C, Alcalay RN, San Luciano M, Ortega R, Raymond D, Mejia-Santana H, Ozelius L, Clark L, Orr-Utreger A, Marder K, Giladi N, Bressman SB.

Ann Clin Transl Neurol · 2014-09-30

DOI: 10.1002/acn3.95PMID: 25493281

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Alpha synuclein is transported into and out of the brain by the blood-brain barrier.

Sui YT, Bullock KM, Erickson MA, Zhang J, Banks WA.

Peptides · 2014-09-30

DOI: 10.1016/j.peptides.2014.09.018PMID: 25278492

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice.

Beccano-Kelly DA, Kuhlmann N, Tatarnikov I, Volta M, Munsie LN, Chou P, Cao LP, Han H, Tapia L, Farrer MJ, Milnerwood AJ.

Front Cell Neurosci · 2014-09-26

DOI: 10.3389/fncel.2014.00301PMID: 25309331

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Protein/lipid coaggregates are formed during α-synuclein-induced disruption of lipid bilayers.

van Maarschalkerweerd A, Vetri V, Langkilde AE, Foderà V, Vestergaard B.

Biomacromolecules · 2014-09-26

DOI: 10.1021/bm500937pPMID: 25210839

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2(R1441G)) transgenic mouse model of Parkinson's disease.

Dranka BP, Gifford A, McAllister D, Zielonka J, Joseph J, O'Hara CL, Stucky CL, Kanthasamy AG, Kalyanaraman B.

Neurosci Lett · 2014-09-26

DOI: 10.1016/j.neulet.2014.09.042PMID: 25263790

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

14.182 articles found

A GCase chaperone improves motor function in a mouse model of synucleinopathy.

Modulation of alpha-synuclein toxicity in yeast using a novel microfluidic-based gradient generator.

Genetic characterization of cognitive impairment in Parkinson's disease.

Early oligomerization stages for the non-amyloid component of α-synuclein amyloid.

Mutant α-synuclein enhances firing frequencies in dopamine substantia nigra neurons by oxidative impairment of A-type potassium channels.

Skin nerve α-synuclein deposits: a biomarker for idiopathic Parkinson disease.

Acute increase of α-synuclein inhibits synaptic vesicle recycling evoked during intense stimulation.

Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?

Alpha synuclein is transported into and out of the brain by the blood-brain barrier.

Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice.

Protein/lipid coaggregates are formed during α-synuclein-induced disruption of lipid bilayers.

A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2(R1441G)) transgenic mouse model of Parkinson's disease.

Filters